Skip to main content

MoneyWorks4Me

Raymed Labs informs about quarterly statement on investor complaints

06 Apr 2016 Evaluate

Raymed Labs has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Uflex 603.00
EPL 224.05
AGI Greenpac 672.55
Huhtamaki India 220.25
TCPL Packaging 4465.50
View more..